Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial

Stefano Palomba, Angela Falbo, Annalisa Di Cello, Fulvio Cappiello, Achille Tolino, Fulvio Zullo

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate the effects of metformin on the ovarian response to gonadotropins given for in vitro fertilization (IVF) programs in patients with polycystic ovary syndrome (PCOS) and reduced ovarian reserve. Design: Prospective, parallel, randomized, double-blind, placebo-controlled clinical trial. Setting: Academic departments of obstetrics and gynecology, and a private IVF center. Patient(s): Primary infertile patients with PCOS older than 35 years and/or with a basal follicle-stimulating hormone (FSH) level higher than 10 IU/L who were scheduled for IVF cycles. Intervention(s): Gonadotropin- releasing hormone agonist flare-up protocol and high starting doses of recombinant FSH plus metformin or placebo tablets. Main Outcome Measure(s): Primary end point: cancellation rate for low ovarian response. Secondary end-points: other clinical, biochemical, and reproductive data. Result(s): Enrollment was stopped after 88 participants had been randomized and analyzed due to an unacceptable increased risk of poor ovarian response in the metformin arm. Statistically significant differences between the metformin and placebo groups were observed in the dose of gonadotropins used, peak estradiol levels, and the number of dominant follicles, retrieved oocytes, and metaphase II oocytes. Conclusion(s): In patients with PCOS and reduced ovarian reserve, metformin worsened the response to gonadotropins, and its administration should be stopped before the start of controlled ovarian hyperstimulation for IVF programs. Clinical Trials Identification Number: NCT01208740.

Original languageEnglish
Pages (from-to)1128-1133
Number of pages6
JournalFertility and Sterility
Volume96
Issue number5
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Polycystic Ovary Syndrome
Metformin
Fertilization in Vitro
Gonadotropins
Randomized Controlled Trials
Placebos
Follicle Stimulating Hormone
Oocytes
Therapeutics
Hospital Obstetrics and Gynecology Department
Controlled Clinical Trials
Metaphase
Gynecology
Gonadotropin-Releasing Hormone
Tablets
Estradiol
Outcome Assessment (Health Care)
Ovarian Reserve
Clinical Trials

Keywords

  • Gonadotropins
  • infertility
  • IVF
  • metformin
  • PCOS
  • poor prognosis
  • poor responder

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial. / Palomba, Stefano; Falbo, Angela; Di Cello, Annalisa; Cappiello, Fulvio; Tolino, Achille; Zullo, Fulvio.

In: Fertility and Sterility, Vol. 96, No. 5, 11.2011, p. 1128-1133.

Research output: Contribution to journalArticle

Palomba, Stefano ; Falbo, Angela ; Di Cello, Annalisa ; Cappiello, Fulvio ; Tolino, Achille ; Zullo, Fulvio. / Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial. In: Fertility and Sterility. 2011 ; Vol. 96, No. 5. pp. 1128-1133.
@article{28f35d8fc09a4b498a32b1189bcf7629,
title = "Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial",
abstract = "Objective: To evaluate the effects of metformin on the ovarian response to gonadotropins given for in vitro fertilization (IVF) programs in patients with polycystic ovary syndrome (PCOS) and reduced ovarian reserve. Design: Prospective, parallel, randomized, double-blind, placebo-controlled clinical trial. Setting: Academic departments of obstetrics and gynecology, and a private IVF center. Patient(s): Primary infertile patients with PCOS older than 35 years and/or with a basal follicle-stimulating hormone (FSH) level higher than 10 IU/L who were scheduled for IVF cycles. Intervention(s): Gonadotropin- releasing hormone agonist flare-up protocol and high starting doses of recombinant FSH plus metformin or placebo tablets. Main Outcome Measure(s): Primary end point: cancellation rate for low ovarian response. Secondary end-points: other clinical, biochemical, and reproductive data. Result(s): Enrollment was stopped after 88 participants had been randomized and analyzed due to an unacceptable increased risk of poor ovarian response in the metformin arm. Statistically significant differences between the metformin and placebo groups were observed in the dose of gonadotropins used, peak estradiol levels, and the number of dominant follicles, retrieved oocytes, and metaphase II oocytes. Conclusion(s): In patients with PCOS and reduced ovarian reserve, metformin worsened the response to gonadotropins, and its administration should be stopped before the start of controlled ovarian hyperstimulation for IVF programs. Clinical Trials Identification Number: NCT01208740.",
keywords = "Gonadotropins, infertility, IVF, metformin, PCOS, poor prognosis, poor responder",
author = "Stefano Palomba and Angela Falbo and {Di Cello}, Annalisa and Fulvio Cappiello and Achille Tolino and Fulvio Zullo",
year = "2011",
month = "11",
doi = "10.1016/j.fertnstert.2011.08.020",
language = "English",
volume = "96",
pages = "1128--1133",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial

AU - Palomba, Stefano

AU - Falbo, Angela

AU - Di Cello, Annalisa

AU - Cappiello, Fulvio

AU - Tolino, Achille

AU - Zullo, Fulvio

PY - 2011/11

Y1 - 2011/11

N2 - Objective: To evaluate the effects of metformin on the ovarian response to gonadotropins given for in vitro fertilization (IVF) programs in patients with polycystic ovary syndrome (PCOS) and reduced ovarian reserve. Design: Prospective, parallel, randomized, double-blind, placebo-controlled clinical trial. Setting: Academic departments of obstetrics and gynecology, and a private IVF center. Patient(s): Primary infertile patients with PCOS older than 35 years and/or with a basal follicle-stimulating hormone (FSH) level higher than 10 IU/L who were scheduled for IVF cycles. Intervention(s): Gonadotropin- releasing hormone agonist flare-up protocol and high starting doses of recombinant FSH plus metformin or placebo tablets. Main Outcome Measure(s): Primary end point: cancellation rate for low ovarian response. Secondary end-points: other clinical, biochemical, and reproductive data. Result(s): Enrollment was stopped after 88 participants had been randomized and analyzed due to an unacceptable increased risk of poor ovarian response in the metformin arm. Statistically significant differences between the metformin and placebo groups were observed in the dose of gonadotropins used, peak estradiol levels, and the number of dominant follicles, retrieved oocytes, and metaphase II oocytes. Conclusion(s): In patients with PCOS and reduced ovarian reserve, metformin worsened the response to gonadotropins, and its administration should be stopped before the start of controlled ovarian hyperstimulation for IVF programs. Clinical Trials Identification Number: NCT01208740.

AB - Objective: To evaluate the effects of metformin on the ovarian response to gonadotropins given for in vitro fertilization (IVF) programs in patients with polycystic ovary syndrome (PCOS) and reduced ovarian reserve. Design: Prospective, parallel, randomized, double-blind, placebo-controlled clinical trial. Setting: Academic departments of obstetrics and gynecology, and a private IVF center. Patient(s): Primary infertile patients with PCOS older than 35 years and/or with a basal follicle-stimulating hormone (FSH) level higher than 10 IU/L who were scheduled for IVF cycles. Intervention(s): Gonadotropin- releasing hormone agonist flare-up protocol and high starting doses of recombinant FSH plus metformin or placebo tablets. Main Outcome Measure(s): Primary end point: cancellation rate for low ovarian response. Secondary end-points: other clinical, biochemical, and reproductive data. Result(s): Enrollment was stopped after 88 participants had been randomized and analyzed due to an unacceptable increased risk of poor ovarian response in the metformin arm. Statistically significant differences between the metformin and placebo groups were observed in the dose of gonadotropins used, peak estradiol levels, and the number of dominant follicles, retrieved oocytes, and metaphase II oocytes. Conclusion(s): In patients with PCOS and reduced ovarian reserve, metformin worsened the response to gonadotropins, and its administration should be stopped before the start of controlled ovarian hyperstimulation for IVF programs. Clinical Trials Identification Number: NCT01208740.

KW - Gonadotropins

KW - infertility

KW - IVF

KW - metformin

KW - PCOS

KW - poor prognosis

KW - poor responder

UR - http://www.scopus.com/inward/record.url?scp=80054996030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054996030&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2011.08.020

DO - 10.1016/j.fertnstert.2011.08.020

M3 - Article

C2 - 21917254

AN - SCOPUS:80054996030

VL - 96

SP - 1128

EP - 1133

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 5

ER -